| Literature DB >> 32352391 |
Sungwon Choi1, Hyung Jin Choi2, Meelim Kim2,1, Youngin Kim3,4, Yoonjeong Go2, Seokoh Lee2, Myeongjin Na1, Younghee Lee2.
Abstract
BACKGROUND: Developing effective, widely useful, weight management programs is a priority in health care because obesity is a major health problem.Entities:
Keywords: cognitive behavioral therapy; digital health care; mobile phone; obesity
Mesh:
Year: 2020 PMID: 32352391 PMCID: PMC7226050 DOI: 10.2196/14817
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1Digital cognitive behavioral therapy (CBT) CONSORT (Consolidated Standards of Reporting Trials) flow diagram. SIMS: Situational Motivation Scale.
Figure 2Diagram of the digital cognitive behavioral therapy (CBT) process.
Figure 3Screenshots of the digital platform (ie, mobile apps) for the participants (top) and screenshots of the digital platform (ie, dashboard) for the therapist (ie, clinical psychologist) (bottom).
Baseline characteristics of participants in both groups.
| Characteristic | Control (ie, app only) (n=25) | Digital CBTa (ie, app + human CBT) (n=45) | |
| Age (years), mean (SD) | 21.0 (2.7) | 22.3 (3.5) | |
|
|
|
| |
|
| Weight (kg) | 71.9 (7.7) | 74.5 (9.0) |
|
| BMI (kg/m2) | 27.7 (2.9) | 28.2 (3.4) |
|
| Fat mass (kg) | 29.3 (6.0) | 30.2 (6.8) |
|
| Fat percent (%) | 40.5 (4.8) | 40.4 (5.4) |
|
| Lean body mass (kg) | 23.8 (3.3) | 24.0 (2.6) |
|
|
|
| |
|
| Fasting glucose (mg/dL) | 87.0 (8.1) | 87.3 (7.4) |
|
| Triglyceride (mg/dL) | 92.2 (35.9) | 93.2 (42.6) |
|
| Total cholesterol (mg/dL) | 184.7 (24.9) | 191.1 (30.4) |
|
| Alanine aminotransferase (U/L) | 12.7 (6.9) | 15.3 (11.9) |
|
| Aspartate aminotransferase (U/L) | 17.0 (4.7) | 16.9 (4.8) |
|
| Gamma-glutamyl transpeptidase (U/L) | 15.3 (8.5) | 21.3 (32.8) |
|
| Leptin (ng/mL) | 37.5 (14.7) | 42.5 (15.3) |
|
| Fasting insulin (µU/mL) | 12.6 (6.1) | 16.1 (9.1) |
| Homeostasis Model for Assessment of Insulin Resistanceb, mean (SD) | 2.8 (1.5) | 3.5 (2.1) | |
|
|
|
| |
|
| Situational Motivation Scale | 77.0 (5.8) | 76.1 (5.7) |
|
| Body Shape Questionnaire-8C | 34.8 (8.9) | 36.2 (7.5) |
|
| Beck Depression Inventory-II in Korean | 14.7 (9.6) | 13.6 (9.0) |
|
| Trait Anxiety Inventory | 47.8 (11.0) | 48.0 (10.4) |
|
| Rosenberg Self-Esteem Scale | 21.9 (6.4) | 19.8 (5.6) |
|
| DEBQc restrained eating scale | 30.6 (7.3) | 29.9 (6.6) |
|
| DEBQ emotional eating scaled | 29.1 (11.6) | 38.0 (10.1) |
|
| DEBQ external eating scaled | 32.0 (7.0) | 34.9 (4.8) |
|
| Automatic Thoughts Questionnaire | 57.6 (26.0) | 57.2 (22.3) |
|
| Yale Food Addiction Scale | 2.2 (1.7) | 3.0 (1.7) |
|
|
|
| |
|
| Living with family | 10 (40) | 27 (60) |
|
| Living alone | 8 (32) | 8 (18) |
|
| Living with roommates | 7 (28) | 9 (20) |
|
| Others | 0 (0) | 1 (2) |
|
|
|
| |
|
| None | 0 (0) | 1 (2) |
|
| Once | 3 (12) | 4 (9) |
|
| Twice | 12 (48) | 15 (33) |
|
| Three times | 3 (12) | 13 (29) |
|
| Four times | 4 (16) | 8 (18) |
|
| Five times | 2 (8) | 4 (9) |
|
| Six times | 1 (4) | 0 (0) |
aCBT: cognitive behavioral therapy.
bInsulin resistance = (insulin [µU/mL] × glucose [mg/dL]) / 405.
cDEBQ: Dutch Eating Behavior Questionnaire.
dThere was a statistical difference between the two groups at baseline.
Figure 4Patterns of changes in mean body weight (A), BMI (B), body fat mass (C), and lean body mass (LBM) (D). CBT: cognitive behavioral therapy. *P<.05; **P<.01.
Figure 5Weight change based on individual data from the experimental group at the 8-week follow-up (A), from the experimental group at the 24-week follow-up (B), from the control group at the 8-week follow-up (C), and from the control group at the 24-week follow-up (D). CBT: cognitive behavioral therapy.
Figure 6Changes in meal calories between experimental and control groups during the intervention period, as well as the contrast of mean energy intake between groups. *P<.05; ** P<.01.
Figure 7Patterns of changes in engagement rate of the experimental and control groups during the intervention period. *P<.05.
Figure 8The correlation between weight change at the long-term follow-up period (24 weeks) and the level of motivation, self-esteem, depression, and anxiety at baseline. Also shown are the correlation between BMI change at the long-term follow-up and the level of motivation at baseline, and the correlation between fat mass change at the long-term follow-up and lean body mass at baseline. K-BDI: Korean version of the Beck Depression Inventory; RSES: Rosenberg Self-Esteem Scale; SIMS: Situational Motivation Scale; TAI: Trait Anxiety Inventory.
Figure 9The clinical efficacy of digital cognitive behavioral therapy (CBT) by applying the optimal cutoff scores of the predictive markers in the clinical setting. The pink line represents the threshold for successful weight loss.